Written and maintained by CASRAI Editorial Board
Last updated
A cell sort either delivers a usable population or it does not, and the difference is decided almost entirely by three settings chosen before the first event is sorted: the nozzle diameter, the sheath pressure paired with it, and the sort mode. Everything else — the panel, the gates, the controls — is shared with analytical cytometry and is covered in Flow Cytometry: Principles, Panel Design, and Gating Workflow. This page is about the sorting-specific decisions on top of that: what each setting physically does, what it costs, how to verify the result, and what to hand your core facility before you book time.
The single most misunderstood of the three is the sort mode. It is not a quality dial and it does not make the instrument “more accurate”. It is a rule for what the sorter does with a conflict — a droplet that contains both a cell you want and a cell you do not. That is the decision you are actually making, and it is why purity and yield cannot both be maximised.
A note on sources before the numbers
Instrument-vendor documentation was not reachable from the system that compiled this page — the major cytometry vendors block automated retrieval, so no vendor manual, application note or specification sheet is cited here. Every number below is taken from a peer-reviewed method paper, and every one is stated together with the cell type and instrument it was measured on. Where a widely-repeated rule of thumb could not be found in that literature, this page says so rather than repeating it. Confirm any setting against your own instrument’s documentation and your core facility’s operator before you run.
Nozzle size: chosen by the largest cell that has to pass through it
The nozzle sets the diameter of the jet, and therefore the volume of a single droplet and the largest particle that can traverse the orifice without clogging it or being sheared. There is a strong convention in cytometry practice that the nozzle should be roughly four to five times the diameter of the cell being sorted. That ratio is repeated constantly in training material, but it could not be located in the peer-reviewed cytometry method literature during the preparation of this page, so it is reproduced here as folklore, not as a verified specification — useful for a first guess, not something to cite.
What is documented is a set of specific nozzle-and-pressure pairings, each validated against a named cell type on a named instrument. These are far more useful than a ratio, because they show how wide the real range is:
| Cell type | Nozzle | Sheath pressure | Instrument / source |
|---|---|---|---|
| Human haematopoietic stem cells (HSC/HSPC) | 85 µm | 45 psi | BD FACSAria — Cossarizza et al., Eur J Immunol 2021 |
| Cells under 20 µm diameter (general) | 85 µm | not stated | BD FACSAria — Nat Commun 2026 |
| Cells over 20 µm, or fragile primary cells | 100 µm | not stated | BD FACSAria — Nat Commun 2026 |
| Mature white adipocytes (large, buoyant, lipid-filled) | 150 µm | 6 psi | Beckman Coulter MoFlo XDP — Cell Rep 2018 |
| Human dermal fibroblasts at replicative senescence | 200 µm | 3.7 psi | Bio-protocol 2023 |
Two things follow from that table. First, the working range of sheath pressure across normal biology spans more than an order of magnitude — 3.7 psi to 45 psi — so there is no universal pressure, and any number quoted without a cell type attached is meaningless. Second, nozzle choice is a hard constraint, not a preference: the senescent-fibroblast protocol reports that sorting simply failed on standard 100–130 µm nozzles because the cells were too large, and succeeded only on a 200 µm nozzle. If your population sits at the large end, the question is not which nozzle is optimal but which nozzles your core actually owns.
The same protocol paper also warns against going too small: for primary cells, one recent method paper recommends avoiding the 70 µm nozzle entirely to limit shear stress, reserving it for robust cell lines. Small nozzles buy speed and droplet frequency at the cost of shear.
Filtering before the nozzle is not optional
A nozzle clog mid-sort costs the run, not just the moment — it destabilises the stream, invalidates the drop delay, and usually means re-sorting from a sample that has now been sitting at room temperature. Filter immediately before loading. The PURE-seq protocol filters through a 40 µm cell strainer ahead of an 85 µm nozzle; the general principle is a strainer comfortably below the orifice diameter, applied after every dissociation and after any step that can re-aggregate cells. If your dissociation is producing clumps in the first place, the reagent choice is the upstream fix — see Cell Dissociation Reagents: Trypsin, Recombinant Enzymes, Collagenase/Dispase and Non-Enzymatic Options.
Sheath pressure: the setting that quietly kills your cells
Sheath pressure is coupled to the nozzle. A given nozzle has a pressure band at which the stream breaks into stable, uniform droplets; run it outside that band and the break-off point wanders, the drop delay goes wrong, and sorted droplets land in the wrong tube. So pressure is not independently tunable — it moves with the nozzle.
Pressure is also the dominant source of mechanical stress on the cell. High pressure means a faster jet, a higher droplet frequency, higher throughput — and higher shear at the orifice and at the point of droplet formation. This is a real and frequently missed cause of poor post-sort viability: the sort looks clean on the instrument, the purity check passes, and the cells fail to attach, fail to expand, or return a degraded transcriptome afterwards. Fragile primary cells, large cells, and cells destined for functional or single-cell sequencing assays are the ones that pay for it.
The practical consequence is that a fragile population needs the opposite of a fast sort: a larger nozzle, a lower pressure, a lower event rate, cooled collection, and an accepted longer run time. The adipocyte and senescent-fibroblast protocols above are both examples of exactly that trade being made deliberately — 6 psi and 3.7 psi respectively, with the throughput cost absorbed.
Event rate is the third lever, and it has documented limits
Throughput is set by how fast events arrive relative to how fast droplets are produced. Push the sample rate up and a rising fraction of droplets contain more than one cell, which the conflict logic below then has to resolve. Two documented ceilings:
- For human HSPC sorting on a FACSAria at 85 µm / 45 psi, the third-edition immunology guidelines advise the event rate should not exceed roughly 7,000 events per second — and explicitly note that this ceiling is specific to that instrument and nozzle, and changes with a different configuration.
- A 2026 single-cell genomics protocol on the same instrument class caps the flow rate at 8 kHz for cell lines and 6 kHz for primary cells, expressly to limit shear stress during hydrodynamic focusing, and additionally caps total sort duration at 60 minutes to limit expression drift in the sorted cells.
Monitor the electronic abort rate and sort efficiency live rather than only at the end. A climbing abort rate mid-run means coincidences are rising — usually because the sample has concentrated by settling, or because clumps are forming — and it is the earliest signal that yield is being thrown away.
Sort mode: a conflict-resolution rule, not a quality setting
A droplet sorter charges and deflects droplets, not cells. It cannot deflect half a droplet. So the entire problem reduces to one question, asked thousands of times a second:
This droplet contains a cell I want. It may also contain a cell I do not want, or a neighbouring droplet may be ambiguous. Do I take it or abort it?
That is a conflict. The sort mode is the standing answer to it. Vendors name the modes differently and some expose them as combinations of yield, purity and phase masks rather than as named presets, but the underlying variable is identical everywhere:
- Purity-biased modes abort every conflicted droplet. Anything ambiguous is discarded, along with the target cell inside it. Purity goes up; recovery goes down by exactly the number of targets that were discarded.
- Yield-biased modes keep conflicted droplets. Every ambiguous event is collected, target and contaminant together. Recovery goes up; purity falls by the number of contaminants that came along.
- Single-cell modes are the strictest form of the purity bias, adding a requirement that the droplet contain one and only one cell, with no ambiguity in adjacent droplets. A 2026 method paper describes it precisely: in single-cell mode the sorter “prioritizes specificity, discarding ambiguous events arising from staining variability, cell clumping, or detector coincidences”, whereas yield mode “captures these ambiguous events to maximize recovery of rare cells, even if this leads to capturing some off-target cells”. This is the mode used for index sorting and for plate-based single-cell deposition, where a well containing two cells silently ruins the data point.
Because both branches act on the same conflicted droplets, you cannot have both. Purity and yield are not two knobs; they are two ends of one knob. Any protocol promising both is either sorting a population so abundant and so well separated that conflicts are rare, or it is not measuring one of the two.
What the trade actually costs, measured
The size of the penalty is rarely quantified, so a concrete measurement is worth more than the principle. In a 2026 Nature Communications rare-cell protocol, human cells were spiked into a mouse background at 1:1000 and sorted on a BD FACSAria. Across target frequencies from 10−3 down to 10−6, the standard (recovery-biased) configuration returned purities above 75%. Switching the same sort to purity mode raised purity to 98% — and reduced cell recovery by 33%.
Read that as the shape of the trade rather than as a constant: a third of the target cells were thrown away to buy the last twenty-odd points of purity. Whether that is a good deal depends entirely on which resource is scarce.
Choosing the mode from the experiment, not from habit
| If your situation is… | Bias toward | Why |
|---|---|---|
| Target is rare (below about 1 in 10,000) and every cell counts | Yield | Discarding a third of an already tiny population may leave too few cells to run anything. Contaminants can often be identified and removed computationally downstream. |
| Cells are fragile primary material and time on the instrument is itself a cost | Yield | Aborting conflicts lengthens the run, and run length is a viability and expression-drift problem in its own right. |
| Downstream assay is functional (culture, transplant, differentiation, suppression assay) | Purity | A contaminating population that proliferates or signals will confound the readout, and no downstream analysis can remove it after the fact. |
| Sorted cells go straight into a bulk measurement (bulk RNA-seq, proteomics, western blot) | Purity | Bulk assays average over everything in the tube; a contaminant is indistinguishable from real signal. |
| Population is pre-enriched or abundant, or cells are a robust line | Purity / single-cell | Conflicts are comparatively rare, so the recovery penalty is small and the purity is nearly free. |
| Depositing one cell per well, or index sorting | Single-cell | A doublet in a well is not a purity problem, it is a wrong data point that looks valid. |
One further consideration that is easy to miss: if the sorted cells will be sequenced at single-cell resolution, off-target cells are often recoverable in analysis, which genuinely changes the calculus toward yield. If the readout is bulk or functional, they are not, and the calculus goes the other way. Decide the mode from the readout.
A stated purity is a prediction until you re-run the sorted tube
The purity figure the sorter reports at the end of a run is derived from the events it classified and the decisions it made. It is not a measurement of what is in the collection tube. Cells are lost to the walls of the tubing, to the tube wall, to incomplete deflection, and to droplets that missed; doublets counted as single events land as two cells; and a gate drawn slightly wrong produces a confidently reported number that is confidently wrong.
Post-sort reanalysis — taking an aliquot of the collected fraction and running it back through the cytometer on the same panel and the same gates — is the only thing that converts the prediction into a measurement. The third-edition immunology guidelines make this explicit in their sorting protocols, instructing operators plainly to verify purity after the sort. Treat a purity claimed in a methods section without a reanalysis as unverified.
Practical points that make the reanalysis meaningful rather than decorative:
- Run the aliquot on the same panel and the same gate coordinates as the sort. A re-drawn gate measures a different thing.
- Reanalysis costs cells. For a very rare population, an aliquot large enough to be statistically meaningful may be a significant fraction of the yield — decide in advance whether you can afford it, and if not, say so rather than quoting an unverified number.
- Include a viability dye in the reanalysis, not only in the sort. Purity and viability are separate questions and the reanalysis is the one chance to answer both from the same tube.
- Record the reanalysis purity, not the instrument-reported purity, in your methods.
Post-sort viability: what to measure, and when
Viability after sorting is a function of everything above — pressure, nozzle, event rate, run duration — plus the handling on either side of the instrument. It is also frequently reported badly: a viability figure measured immediately after the sort can look reassuring while the cells go on to fail in culture 24 hours later, because membrane-integrity dyes detect cells that are already dead, not cells that have been committed to dying.
What the literature does with this is instructive. The senescent-fibroblast protocol assessed viability by comparing trypan blue exclusion in the sorted fraction against the same population before sorting, and reported an approximately two-fold increase in trypan-blue-positive cells after sorting — a difference that did not reach statistical significance, with the sorted fraction remaining at roughly 15% membrane-compromised cells. Note both halves of that: a pre-sort comparator, and an honest statement of the residual level. A post-sort viability number without a pre-sort baseline says nothing about what the sort did.
A workable practice:
- Measure a pre-sort baseline on the same sample. Trypan blue on a haemocytometer is adequate and cheap — see Hemocytometer Cell Counting and Viability for the counting and dilution mechanics.
- Include a viability dye in the sort panel itself so dead cells are gated out rather than sorted, and so the sort report and reanalysis are directly comparable.
- Collect into protein-containing, buffered medium, cold. Collection tubes pre-loaded with medium or serum, held at 4 °C, are standard across every protocol cited on this page; the 2026 protocol runs its collection tubes on a cooling unit at 4 °C for the whole sort.
- Cap the run. Long sorts degrade viability and shift expression. A 60-minute ceiling is used explicitly for that reason in the single-cell protocol cited above.
- Re-check at 24 hours, not only at time zero, whenever the downstream assay depends on the cells being functional rather than merely present.
- If the sorted cells are going into storage rather than straight into an assay, the handling immediately after collection matters as much as the sort — see Cryopreservation of Cells.
If the sorted material is destined for RNA work, viability is not the endpoint that matters — RNA integrity is, and it degrades with sort duration and handling temperature independently of membrane integrity. Check it directly rather than inferring it; RNA Integrity Number (RIN): How It Is Computed and How to Read a Trace covers what the trace actually shows and where the number misleads.
Sterility, if the cells are going back into culture
A sorter is not a sterile instrument by default. The fluidics are shared between users and samples, the sheath tank is a large volume of buffer at room temperature, and the stream is open to air at the point of droplet formation. If the sorted cells are going back into culture, transplant or long-term expansion, sterility is a separate requirement from purity and viability, and it is arranged in advance with the core, not assumed:
- Ask what the sterilisation procedure between users actually is, and whether a sterile sheath fluid and a fresh, decontaminated sheath tank are used for aseptic sorts.
- Include antibiotics in the collection medium for the sort itself if your downstream culture tolerates them, and plan a wash step.
- Handle the collection tubes with the same discipline as any open-culture step — see Aseptic Technique.
- Test the sorted line for mycoplasma afterwards, not only the parent line. A sort is a plausible introduction point, and mycoplasma is invisible in every readout above. Mycoplasma Testing Methods Compared sets out which method detects what and how long each takes.
Aerosol containment for biohazardous sorts
Droplet sorting generates aerosols by design: the stream is deliberately broken into free droplets in air, and any stream instability, partial clog or failed break-off sprays them. That makes sorting a materially different exposure problem from analysis on a closed instrument, even for the identical sample. Unfixed primary human material, any BSL-2-or-higher agent, and any sample of unknown infectious status all fall into this category.
The reference standard is the International Society for the Advancement of Cytometry cell sorter biosafety standards (Cytometry Part A 2014;85:434–453, doi:10.1002/cyto.a.22454). Two points from the surrounding literature are worth stating plainly:
- Containment is something you test, not something you assume. Validated aerosol-containment testing methods for cell sorters exist and are published — for example the impactor and microsphere-based containment assay described in Cytometry Part A 2019;95:173–182 (doi:10.1002/cyto.a.23680). “The sorter has an enclosure” is not evidence that the enclosure contains; a containment test is.
- The determination is not yours to make alone. Requirements vary by agent, by instrument (some sorters are certified for enclosed BSL-2 use and some are not) and by institution, and an instrument-specific risk assessment with institutional biosafety committee approval is the normal gate before a biohazardous sort is scheduled.
For the containment framework this sits inside, see Biosafety Levels BSL-1 to BSL-4; for the enclosure hardware and the technique that makes it work, biosafety cabinet and how to use a biosafety cabinet. Sample preparation for a biohazardous sort, and the biosafety approval path around it, are also covered from the transfection side in Transfection: Choosing a Method, Optimising It, and the Biosafety Approval You Need.
What to bring to the core facility before you book
Almost nobody owns a sorter; sorting is bought as operator time from a shared facility, and the setup decisions above are made jointly with the operator. Arriving with these answers turns a diagnostic session into a productive one:
- The approximate diameter of your target cells, and whether they are fragile, adherent-derived, lipid-laden or unusually large. This determines the nozzle, and the nozzle determines nearly everything else.
- The frequency of the target population in the starting sample, and the total number of cells you need out. These two numbers set the run time, and run time is what you are being charged for.
- The downstream assay, stated concretely. “Bulk RNA-seq”, “one cell per well for plate-based sequencing”, and “transplant into recipient animals” imply three different sort modes and three different sterility requirements.
- Whether purity or yield is the binding constraint, decided by you in advance rather than by the operator’s default.
- The biosafety status of the material, and any existing IBC approval, before the booking rather than on the day.
- Collection medium and temperature, and whether you need a cooled collection device.
The administrative side of this — recharge rates, why sorter time is priced above unassisted analysis, and how to budget instrument time on a grant — is covered in the analytical guide and in Core Facility (Research Core).
What to report in a methods section
A sort is reproducible only if these are stated. Most published methods sections omit at least half of them:
- Instrument make and model, nozzle diameter, and sheath pressure.
- Sort mode or mask configuration, named as the instrument names it.
- Event rate and total sort duration.
- Gating strategy and the full panel, including the viability dye.
- Post-sort reanalysis purity, identified as such and distinguished from the instrument-reported purity.
- Viability before and after the sort, with the method used to measure it.
- Collection medium and temperature.
Reporting-standard compliance for the cytometry data itself (MIFlowCyt, FCS deposition) is covered in the analytical guide. For the imaging-side equivalent of these instrument-parameter reporting questions, see Spinning-Disk vs Point-Scanning Confocal, where the same principle applies: the acquisition parameters are the experiment.
This guide sits in CASRAI’s laboratory equipment and instrumentation cluster.
Frequently asked questions
What nozzle size should I use for cell sorting?
Choose it from the diameter of your largest target cell. Documented pairings include 85 µm for cells under about 20 µm, 100 µm for larger or fragile cells, 150 µm for mature adipocytes and 200 µm for senescent fibroblasts. The commonly repeated rule that the nozzle should be four to five times the cell diameter could not be verified in the peer-reviewed method literature and should be treated as a starting guess only. Ask your core which nozzles the instrument actually has — that constraint usually decides it.
What sheath pressure should I sort at?
There is no universal answer, and any number quoted without a cell type attached is not usable. Published protocols range from 3.7 psi for senescent fibroblasts on a 200 µm nozzle to 45 psi for human haematopoietic stem cells on an 85 µm nozzle. Pressure is coupled to the nozzle: each nozzle has a band in which the stream breaks into stable droplets, and you work inside that band.
What is the difference between purity mode and yield mode?
Both describe what the sorter does with a conflicted droplet — one containing both a target and a non-target cell, or one whose neighbours are ambiguous. Purity-biased modes abort those droplets, so contaminants are excluded and the target cells inside them are lost. Yield-biased modes collect them, so recovery is maximised and contaminants come along. They act on the same droplets in opposite directions, which is why you cannot maximise both.
How much yield does purity mode actually cost?
In one measured example — human cells spiked into a mouse background at 1:1000 and sorted on a BD FACSAria — switching to purity mode raised purity from above 75% to 98% and reduced cell recovery by 33%. Treat that as the shape of the trade rather than a fixed constant; the penalty depends on how frequent conflicts are, which depends on target frequency and event rate.
When should I use single-cell mode?
When one cell per well is the requirement rather than a preference: plate-based single-cell sequencing, index sorting, clonal outgrowth. It is the strictest purity bias, discarding ambiguous events arising from staining variability, clumping or detector coincidences, and it costs the most recovery. For a bulk collection it is usually unnecessary.
Why is my post-sort viability poor?
The usual mechanical cause is excessive shear: too small a nozzle at too high a pressure for the cell type, often compounded by a high event rate and a long run. Fragile primary cells, large cells and lipid-laden cells are the most affected. The fix is the opposite of a fast sort — larger nozzle, lower pressure, lower event rate, cooled protein-containing collection medium, capped run duration. Non-mechanical causes to rule out first are the dissociation step and the time the sample spent at room temperature before loading.
Do I need to re-run the sorted cells to confirm purity?
Yes, if you intend to state a purity. The figure the instrument reports is derived from its own sorting decisions, not from what ended up in the tube. Running an aliquot of the collected fraction back through the same panel and the same gates is what turns it into a measurement, and published sorting protocols instruct operators to verify purity after the sort.
Is cell sorting the same thing as FACS?
In everyday use, yes. FACS — fluorescence-activated cell sorting — was originally a BD trademark and is now used generically for fluorescence-based droplet sorting. Not all cell sorting is fluorescence-activated, though: magnetic bead-based separation is a distinct method, frequently used to pre-enrich a rare population before a sort so that the sorter starts from a higher target frequency and runs for less time.
What extra precautions apply to sorting biohazardous material?
Droplet sorting generates aerosols by design, so it is a different exposure problem from analysis on a closed instrument even for the same sample. The reference standard is the ISAC cell sorter biosafety standards (Cytometry Part A 2014;85:434–453). Expect an instrument-specific risk assessment, institutional biosafety committee approval, an aerosol management system or enclosure, and a validated decontamination procedure — and note that containment is verified by a published containment test, not assumed from the presence of an enclosure.
How do I sort cells that are too large for a standard nozzle?
Use a larger nozzle at a lower pressure and accept the throughput cost. Sorting senescent human dermal fibroblasts failed outright on standard 100–130 µm nozzles and succeeded on a 200 µm nozzle at 3.7 psi; mature white adipocytes are sorted at 150 µm and 6 psi. Instrument detector settings may also need adjusting, since very large cells can saturate the forward-scatter channel and become invisible on a default plot.
Sources
- Cossarizza A, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). European Journal of Immunology 2021;51:2708–3145. doi:10.1002/eji.202170126
- International Society for the Advancement of Cytometry cell sorter biosafety standards. Cytometry Part A 2014;85:434–453. doi:10.1002/cyto.a.22454
- Novel Impactor and Microsphere-Based Assay Used to Measure Containment of Aerosols Generated in a Flow Cytometer Cell Sorter. Cytometry Part A 2019;95:173–182. doi:10.1002/cyto.a.23680
- PURE-seq integrates FACS and PIP-seq for single-cell genomics of ultra-rare cells. Nature Communications 2026;17:1408. doi:10.1038/s41467-025-68146-w
- Flow Cytometry-based Method for Efficient Sorting of Senescent Cells. Bio-protocol 2023;13:e4612. doi:10.21769/BioProtoc.4612
- Flow Cytometry of Mouse and Human Adipocytes for the Analysis of Browning and Cellular Heterogeneity. Cell Reports 2018;24:2746–2756. doi:10.1016/j.celrep.2018.08.006








